Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel · Delayed Price · Currency is ILS · Price in ILA 30.00
-0.30 (-0.99%)
Feb 20, 2026, 1:44 PM IDT
TLV:CBI Market Cap
TLV:CBI has a market cap or net worth of 47.05 million as of February 20, 2026. Its market cap has decreased by -18.92% in one year.
Market Cap
47.05M
Enterprise Value
72.90M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
30.00
Market Cap Chart
Since July 23, 2007, TLV:CBI's market cap has decreased from 797.05M to 47.05M, a decrease of -94.10%. That is a compound annual growth rate of -14.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 47.05M | -1.32% |
| Dec 31, 2025 | 47.68M | -12.89% |
| Dec 31, 2024 | 54.74M | -12.09% |
| Dec 31, 2023 | 62.27M | -36.78% |
| Dec 29, 2022 | 98.50M | -46.87% |
| Dec 30, 2021 | 185.39M | -41.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 589.80M |
| Geffen Residence & Renewal | 267.24M |
| Matricelf | 148.89M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 30.97M |
| XTL Biopharmaceuticals | 25.55M |
| Evogene | 24.91M |
| Purple Biotech | 18.58M |